Hardian Health UK AI compliance review (Sector-Specific Platforms) — Three harmonised curved smoked-glass arcs intersecting over a UK regulatory blueprint plane
Sector-Specific Platforms · London / Haywards Heath, UK (HARDIAN LIMITED #11237413)

Hardian Health — UK AI Compliance Profile

MHRA AI Airlock / PCCP, NICE QALY health economics, NHS DTAC v2.0, DCB0129 CSO & DSPT v8.

UK Verdict: UK healthtech startups, NHS trusts, AVT AI scribes, and SaMD/AIaMD developers preparing MHRA PCCPs and DTAC v2.0 submissions. Indicative Cost: Verified Opaque — Custom Project Fees & Consultancy Retainers.

Overview & UK Market Presence

Operating as HARDIAN LIMITED (#11237413), Hardian Health acts as UK Responsible Person (UKRP) across a 14-step SaMD/AIaMD approval journey, combining NICE Markov/QALY health economics with MHRA AI Airlock (Eye2Gene Phase 2), forthcoming Predetermined Change Control Plans (PCCPs), July 2026 AVT/AI scribe boundaries, and NHS DTAC v2.0 / DCB0129 CSO / DSPT v8.

UK Footprint: UK clinical & regulatory AI consultancy (HARDIAN LIMITED, #11237413); MHRA AI Airlock Phase 2 partner (Eye2Gene), Amwell NHS access & NIHR grants.

Watch-out / Limitation: Verified Opaque consultancy pricing dedicated exclusively to healthcare and medical AI rather than general SaaS.

Products Sold & Core Capabilities

  • 14-Step MHRA AIaMD / UKCA Regulatory Strategy & PCCPs (AI Airlock Partner)
  • NICE QALY Health Economics & Markov Budget-Impact Modelling
  • NHS DTAC v2.0 (WCAG 2.2 AA), DCB0129 / DCB0160 CSO & DSPT v8 Files
  • UK Responsible Person (UKRP), EU Authorised Rep & ISO 13485 eQMS

Key UK Highlights

  • Direct MHRA AI Airlock Phase 2 experience (Eye2Gene) + NIHR & Amwell NHS market-access record
  • Covers 2026 DTAC v2.0 (mandatory 6 Apr 2026), DCB0129 CSO, DSPT v8 & July 2026 AVT rules
  • Combines regulatory UKRP approval with NICE QALY health-economic budget impact cases
Evaluation DimensionHardian Health Details
CategorySector-Specific AI Compliance (FCA, HR & MHRA/NHS)
Supported FrameworksMHRA AIaMD & PCCPs · NHS DTAC v2.0 & DSPT v8 · NHS DCB0129 / DCB0160 · ISO 13485 · EU MDR
Pricing Model & Indicative BandVerified Opaque — Custom Project Fees & Consultancy Retainers — Custom project fees and fractional UKRP / clinical safety retainers tailored to device class and NICE evidence scope.
Target Company SizesSME (<50), Mid-Market (50–499), Enterprise (500+)
Official Website & Review Datehttps://www.hardianhealth.com ↗ (Reviewed 2026-11-16)

Alternatives in Sector-Specific Platforms

  • Aveni AI — Edinburgh FinLLM & 100% FCA Consumer Duty QA: Advisory modules £99–£299/user/mo; Detect custom quoted.
  • Warden AI — UK Equality Act 2010 (s.19 Essop & s.60) & NYC LL144 HR bias audits across 15+ demographic classes.
Compare All in Sector-Specific Platforms →